4//SEC Filing
Entia Biosciences, Inc. 4
Accession 0001469709-13-000381
CIK 0001408299operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:44 PM ET
Size
10.6 KB
Accession
0001469709-13-000381
Insider Transaction Report
Form 4
SOBOL PHILIP A
Director
Transactions
- Purchase
Convertible Promissory Note
2013-06-11$40000.00/sh+1$40,000→ 25,000 totalExercise: $5.00From: 2013-06-11Exp: 2013-12-31→ Series A Preferred Stock (8,000 underlying) - Purchase
Common Stock Purchase Warrants
2013-06-11$0.45/sh+10,000$4,500→ 10,000 totalExercise: $0.45From: 2013-07-01Exp: 2018-06-10→ Common Stock (10,000 underlying) - Purchase
Series A Preferred Stock
2013-06-11$5.00/sh+11,338$56,690→ 19,338 total(indirect: By Trust)Exercise: $0.50From: 2013-06-11→ Common Stock (113,380 underlying)
Footnotes (3)
- [F1]The conversion price is adjustable pursuant to certain anti-dilution provisions.
- [F2]The preferred shares are convertible into common shares at any time, but under certain circumstances there could be a mandatory conversion, as for example after the anniversary of the effectiveness of a registration statement covering the common stock underlying the preferred shares or within 30 days of the closing of a private placement exceeding $5 million.
- [F3]These shares of Series A preferred stock are being issued pursuant to the conversion of principal and accrued interest on a promissory note held by Dr. Sobol.
Documents
Issuer
Entia Biosciences, Inc.
CIK 0001408299
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001408299
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:44 PM ET
- Size
- 10.6 KB